FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178335005> ?p ?o ?g. }

• W3178335005 endingPage "1561" @default.
• W3178335005 startingPage "1555" @default.
• W3178335005 abstract "<h2>Abstract</h2><h3>Background</h3> In this study, we investigate the effects of low serum TB drug level on treatment outcome among TB patients with slow response in South Korea, where the prevalence of rapid acetylator is relatively high. <h3>Methods</h3> Among the pulmonary TB patients whose treatment outcomes were reported between 2014 and 2018 at Incheon St. Mary hospital, those who underwent TDM because of delayed culture conversion or reversion were included. Primary outcome was microbiological failure defined as (1) positive sputum culture after 120 days of treatment, or (2) culture-confirmed relapse within one year after treatment completion. Patients with culture conversion within 120 days and no relapse were classified as the final conversion group. Clinical characteristics and serum drug concentration at 2 h after administration (C_2hr) were compared between those two groups. <h3>Results</h3> A total of 55 pulmonary TB patients were included. Prevalence of subtherapeutic range of C_2hr for isoniazid and rifampin was 78.2% and 21.8%, respectively. With one year of follow-up, 21 cases were classified as the microbiological failure group, and 34 cases as the final conversion group. In a multivariable logistic regression model for predicting microbiological failure, C_2hr of isoniazid was the most significant predictor after adjusting for the effects of age and sex (adjusted odds ratio, 0.29; <i>p</i> = 0.009). In a tree-based classification model, C_2hr of isoniazid with cutoff level 2.5 μg/ml was the most important variable for predicting microbiological failure. <h3>Conclusions</h3> Low serum isoniazid level was related to poor treatment outcomes among the TB patients with slow response." @default.
• W3178335005 created "2021-07-19" @default.
• W3178335005 creator A5000364219 @default.
• W3178335005 creator A5006787063 @default.
• W3178335005 creator A5035419746 @default.
• W3178335005 creator A5057467146 @default.
• W3178335005 creator A5070705259 @default.
• W3178335005 creator A5090041263 @default.
• W3178335005 date "2021-11-01" @default.
• W3178335005 modified "2023-09-25" @default.
• W3178335005 title "Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response – A retrospective cohort study" @default.
• W3178335005 cites W117549336 @default.
• W3178335005 cites W1822558447 @default.
• W3178335005 cites W1979732039 @default.
• W3178335005 cites W1995044095 @default.
• W3178335005 cites W2011863437 @default.
• W3178335005 cites W2019883403 @default.
• W3178335005 cites W2027951201 @default.
• W3178335005 cites W2034515133 @default.
• W3178335005 cites W2042232668 @default.
• W3178335005 cites W2056450991 @default.
• W3178335005 cites W2075098875 @default.
• W3178335005 cites W2076664566 @default.
• W3178335005 cites W2095750649 @default.
• W3178335005 cites W2096152930 @default.
• W3178335005 cites W2105544821 @default.
• W3178335005 cites W2107834145 @default.
• W3178335005 cites W2108827147 @default.
• W3178335005 cites W2109526601 @default.
• W3178335005 cites W2116611451 @default.
• W3178335005 cites W2122682841 @default.
• W3178335005 cites W2133530219 @default.
• W3178335005 cites W2148981816 @default.
• W3178335005 cites W2151487264 @default.
• W3178335005 cites W2160753277 @default.
• W3178335005 cites W2170012142 @default.
• W3178335005 cites W2218442983 @default.
• W3178335005 cites W2327719413 @default.
• W3178335005 cites W2516938750 @default.
• W3178335005 cites W2887216093 @default.
• W3178335005 cites W2887662393 @default.
• W3178335005 cites W2889510886 @default.
• W3178335005 cites W2898142636 @default.
• W3178335005 cites W2933620934 @default.
• W3178335005 cites W2969746584 @default.
• W3178335005 cites W2981983006 @default.
• W3178335005 cites W2990226359 @default.
• W3178335005 doi "https://doi.org/10.1016/j.jiac.2021.06.016" @default.
• W3178335005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34238662" @default.
• W3178335005 hasPublicationYear "2021" @default.
• W3178335005 type Work @default.
• W3178335005 sameAs 3178335005 @default.
• W3178335005 citedByCount "1" @default.
• W3178335005 countsByYear W31783350052022 @default.
• W3178335005 crossrefType "journal-article" @default.
• W3178335005 hasAuthorship W3178335005A5000364219 @default.
• W3178335005 hasAuthorship W3178335005A5006787063 @default.
• W3178335005 hasAuthorship W3178335005A5035419746 @default.
• W3178335005 hasAuthorship W3178335005A5057467146 @default.
• W3178335005 hasAuthorship W3178335005A5070705259 @default.
• W3178335005 hasAuthorship W3178335005A5090041263 @default.
• W3178335005 hasConcept C126322002 @default.
• W3178335005 hasConcept C141071460 @default.
• W3178335005 hasConcept C142724271 @default.
• W3178335005 hasConcept C151956035 @default.
• W3178335005 hasConcept C156957248 @default.
• W3178335005 hasConcept C167135981 @default.
• W3178335005 hasConcept C201903717 @default.
• W3178335005 hasConcept C2776301714 @default.
• W3178335005 hasConcept C2776967927 @default.
• W3178335005 hasConcept C2777768864 @default.
• W3178335005 hasConcept C2779912665 @default.
• W3178335005 hasConcept C2781069245 @default.
• W3178335005 hasConcept C71924100 @default.
• W3178335005 hasConcept C72563966 @default.
• W3178335005 hasConceptScore W3178335005C126322002 @default.
• W3178335005 hasConceptScore W3178335005C141071460 @default.
• W3178335005 hasConceptScore W3178335005C142724271 @default.
• W3178335005 hasConceptScore W3178335005C151956035 @default.
• W3178335005 hasConceptScore W3178335005C156957248 @default.
• W3178335005 hasConceptScore W3178335005C167135981 @default.
• W3178335005 hasConceptScore W3178335005C201903717 @default.
• W3178335005 hasConceptScore W3178335005C2776301714 @default.
• W3178335005 hasConceptScore W3178335005C2776967927 @default.
• W3178335005 hasConceptScore W3178335005C2777768864 @default.
• W3178335005 hasConceptScore W3178335005C2779912665 @default.
• W3178335005 hasConceptScore W3178335005C2781069245 @default.
• W3178335005 hasConceptScore W3178335005C71924100 @default.
• W3178335005 hasConceptScore W3178335005C72563966 @default.
• W3178335005 hasIssue "11" @default.
• W3178335005 hasLocation W31783350051 @default.
• W3178335005 hasOpenAccess W3178335005 @default.
• W3178335005 hasPrimaryLocation W31783350051 @default.
• W3178335005 hasRelatedWork W1970323245 @default.
• W3178335005 hasRelatedWork W1987247410 @default.
• W3178335005 hasRelatedWork W2181447735 @default.
• W3178335005 hasRelatedWork W2345419290 @default.
• W3178335005 hasRelatedWork W238453737 @default.

• next